Seer (SEER) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Executive summary
Received a revised, highly contingent, non-binding, and unsolicited acquisition proposal from Bradley L. Radoff, Michael Torok, and affiliates on April 24, 2026.
Board of Directors unanimously rejected the revised unsolicited proposal as announced in a press release dated April 27, 2026.
Voting matters and shareholder proposals
Soliciting material filed pursuant to Rule 14a-12, indicating upcoming or ongoing solicitation of shareholder votes.
Board of directors and corporate governance
Board acted unanimously in rejecting the unsolicited acquisition proposal.
President and CFO David Horn signed the report, confirming board actions and decisions.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Seer
- Board rejects acquisition proposal; proxy process for 2026 Annual Meeting initiated.SEER
Proxy filing27 Apr 2026 - Board rejects revised unsolicited proposal, affirms strategy, and prepares for 2026 proxy vote.SEER
Proxy filing27 Apr 2026 - Received unsolicited acquisition proposal and director nominations; board review underway.SEER
Proxy filing14 Apr 2026 - Acquisition proposal and board nominations prompt detailed review ahead of 2026 Annual Meeting.SEER
Proxy filing13 Apr 2026 - Strong growth, innovation, and new detector tech set the stage for future expansion.SEER
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - 2025 revenue rose 17% to $16.6M, with improved margins and a 67% increase in installed base.SEER
Q4 202526 Feb 2026 - Q2 revenue fell 23% to $3.1M; guidance cut, but cash remains strong and pipeline is growing.SEER
Q2 20242 Feb 2026 - High-impact publications and scientific validation drive optimism for growth in 2025.SEER
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Proteograph's robust, scalable platform accelerates unbiased biomarker discovery and scientific adoption.SEER
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026